Skip to content

Theravance Biopharma, Inc.: filings

Every Theravance Biopharma, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 2026401160001104659-26-093773
10-Q2026-05-07fiscal Q1 202640830001104659-26-056760
10-K2026-03-23fiscal FY 2025491470001104659-26-033077
10-Q2025-11-12fiscal Q3 2025411200001104659-25-110382
10-Q2025-08-13fiscal Q2 2025401160001558370-25-011408
10-Q2025-05-12fiscal Q1 202539800001558370-25-007398
10-K2025-03-07fiscal FY 2024461410001558370-25-002447
10-Q2024-11-14fiscal Q3 2024391130001558370-24-015602
10-Q2024-08-08fiscal Q2 2024391130001558370-24-011636
10-Q2024-05-15fiscal Q1 202438800001558370-24-008201
10-K2024-03-01fiscal FY 2023471410001558370-24-002267
10-Q2023-11-09fiscal Q3 2023391130001558370-23-018612
10-Q2023-08-09fiscal Q2 2023391130001558370-23-014070
10-Q2023-05-10fiscal Q1 202339800001558370-23-008951
10-K2023-03-01fiscal FY 2022481700001558370-23-002595
10-Q2022-11-09fiscal Q3 2022401120001558370-22-017048
10-Q2022-08-08fiscal Q2 2022401140001558370-22-012666
10-Q2022-05-06fiscal Q1 202238790001558370-22-007651
10-K2022-02-28fiscal FY 2021481710001558370-22-002373
10-Q2021-11-08fiscal Q3 2021401160001558370-21-014907
10-Q2021-08-05fiscal Q2 2021381090001558370-21-010555
10-Q2021-05-06fiscal Q1 202138780001558370-21-006234
10-K2021-02-26fiscal FY 2020471510001558370-21-002006
10-Q2020-11-09fiscal Q3 2020381070001558370-20-013233
10-Q2020-08-10fiscal Q2 2020381070001558370-20-010023
10-Q2020-05-08fiscal Q1 202038770001558370-20-006021
10-K2020-02-27fiscal FY 2019471500001558370-20-001644
10-Q2019-11-08fiscal Q3 2019421140001558370-19-010487
10-Q2019-08-05fiscal Q2 2019421140001558370-19-007084
10-Q2019-05-10fiscal Q1 201940790001558370-19-004767
10-K2019-02-28fiscal FY 2018451470001558370-19-001346
10-Q2018-11-08fiscal Q3 2018381000001558370-18-008888
10-Q2018-08-02fiscal Q2 2018381010001558370-18-006147
10-Q2018-05-09fiscal Q1 201834690001558370-18-004404
10-K2018-02-28fiscal FY 2017431470001047469-18-001160
10-Q2017-11-08fiscal Q3 201737980001104659-17-066731
10-Q2017-08-09fiscal Q2 201737980001104659-17-050414
10-Q2017-05-10fiscal Q1 201733680001104659-17-031264
10-K2017-03-01fiscal FY 2016421440001047469-17-001086
10-Q2016-11-09fiscal Q3 201632860001104659-16-155621
10-Q2016-08-09fiscal Q2 201633880001104659-16-138040
10-Q2016-05-10fiscal Q1 201632660001104659-16-119714
10-K2016-03-11fiscal FY 2015391350001047469-16-011039
10-Q2015-11-12fiscal Q3 201533880001104659-15-078317
10-Q2015-08-13fiscal Q2 201533880001104659-15-059580
10-Q2015-05-13fiscal Q1 201532660001104659-15-037749
10-K2015-03-13fiscal FY 2014381330001047469-15-002175
10-Q2014-11-12fiscal Q3 201432890001104659-14-079772
10-Q2014-08-14fiscal Q2 201430810001104659-14-060469
10-Q2014-06-24fiscal Q1 201423480001104659-14-048072

Inspect the source

Entity
Theravance Biopharma, Inc. / CIK 0001583107
Captured
2026-09-19T11:19:18.148Z
SEC response SHA-256
3526ec0d3f81387c03caa1ef2904c1cfb1ce908cb40338946f71478c67c40012

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001583107.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))